Tuyển tập các báo cáo nghiên cứu về hóa học được đăng trên tạp chí hóa học đề tài : Preferences of diabetes patients and physicians: A feasibility study to identify the key indicators for appraisal of health care values | Porzsolt et al. Health and Quality of Life Outcomes 2010 8 125 http content 8 1 125 HEALTH AND QUALITY of life outcomes RESEARCH Open Access Preferences of diabetes patients and physicians A feasibility study to identify the key indicators for appraisal of health care values Franz Porzsolt 1 Johannes Clouth2 Marc Deutschmann3 Hans-J Hippier4 Abstract Background Evidence-based medicine the Institute of Medicine IOM and the German Institute for Quality and Efficiency in Health Care IQWiG support the inclusion of patients preferences in health care decisions. In fact there are not many trials which include an assessment of patient s preferences. The aim of this study is to demonstrate that preferences of physicians and of patients can be assessed and that this information may be helpful for medical decision making. Method One of the established methods for assessment of preferences is the conjoint analysis. Conjoint analysis in combination with a computer assisted telephone interview CATI was used to collect data from 827 diabetes patients and 60 physicians which describe the preferences expressed as levels of four factors in the management and outcome of the disease. The first factor described the main treatment effect reduction of elevated HbA1c improved well-being absence of side effects and no limitations of daily life . The second factor described the effect on the body weight gain no change reduction . The third factor analyzed the mode of application linked to meals or flexible application . The fourth factor addressed the type of product original brand or generic product . Utility values were scaled and normalized in a way that the sum of utility points across all levels is equal to the number of attributes factors times 100. Results The preference weights confirm that the reduction of body weight is at least as important for patients -especially obese patients - and physicians as the reduction of an elevated HbA1c. Original products were .
